3 полученные результаты
TECHNICAL FIELD
The invention herein is directed to enhancing the delivery of large neutral amino acid drugs and large neutral amino acid glutathione depleting agents in the treatment of diseases where crossing the blood-brain barrier by the drugs and/or agents is necessary.
BACKGROUND OF THE
FIELD OF THE INVENTION
The present invention relates to compounds and their uses, and in particular to compounds and their therapeutic use in the treatment or prevention of conditions having an association with substrates, such as the neurotransmitter anandamide, which are broken down by the fatty
FIELD OF THE INVENTION
The present invention relates to compounds and their uses, and in particular to compounds and their therapeutic use in the treatment or prevention of conditions having an association with substrates, such as the neurotransmitter anandamide, which are broken down by the fatty